Aldeyra has since resubmitted its application, buffing it up with a “single clinical trial that achieved the primary endpoint ...
The biotech has a deck of RASP modulators. As Aldeyra has accrued evidence in a range of indications, management has shuffled the pack by changing its priority assets in specific diseases. The company ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative ...
Pharmaceutical Technology on MSN
Aldeyra reshuffles pipeline, culling asset despite Phase II success
Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...
Discover a study showing how urethra-sparing robot-assisted simple prostatectomy preserves ejaculatory function while ...
Cybersecurity is an asymmetrical battle. While enterprises plough thousands of hours and millions of dollars into securing their data, attackers only require, relatively speaking, a miniscule ...
Sgt. Zachary Gibson joined the U.S. Army in 2011 as a petroleum supply specialist. While proud to serve his country in any capacity, the Batavia, New York, native said he always felt the need to ...
Michael has been writing about entertainment since 2016, but he's been a gamer since playing Pac-Man in the arcade, Kings Quest 3 on the PC, and the Sega Master System he got from his late father. In ...
ASX-listed Broken Hill Mines (BHM) has secured firm commitments to raise A$38.5-million through a share placement aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results